Currently, there exists no efficient treatment for GNAO1 encephalopathy, apart from the limited efficiency of deep-brain stimulation that represents a symptomatic (but often life-saving) treatment for the severe episodes of motor dysfunction, without affecting the other disease manifestations such as epilepsy or developmental delay [3,26]. This evidence concerns the gene GNAO1 and Encephalopathy.